Loss of Glycosaminoglycan Receptor Binding after Mosquito Cell Passage Reduces Chikungunya Virus Infectivity

PLoS Neglected Tropical Diseases

Volumn 9, Issue 10, 2015, Pages

  Acharya, Dhiraj ^a   Paul, Amber M ^a   Anderson, John F ^b   Huang, Faqing ^a   Bai, Fengwei ^a  

^a The University of Southern Mississippi   (United States)

^b Connecticut Agricultural Experiment Station ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; GLYCOSAMINOGLYCAN RECEPTOR; HEPARIN; TUNICAMYCIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RECEPTOR; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL VIABILITY ASSAY; CHIKUNGUNYA; CHIKUNGUNYA VIRUS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; MOSQUITO; NONHUMAN; PLAQUE FORMING CELL ASSAY; PROTEIN GLYCOSYLATION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR BINDING; SEQUENCE ANALYSIS; VIREMIA; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS REPLICATION; ANIMAL; CELL LINE; CHLOROCEBUS AETHIOPS; CYTOPATHOGENIC EFFECT; DISEASE MODEL; METABOLISM; MOUSE; PATHOLOGY; PHYSIOLOGY; VIROLOGY; VIRULENCE;

ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; CHIKUNGUNYA FEVER; CHIKUNGUNYA VIRUS; CULICIDAE; CYTOPATHOGENIC EFFECT, VIRAL; DISEASE MODELS, ANIMAL; HUMANS; MICE; RECEPTORS, CELL SURFACE; RECEPTORS, VIRUS; VIREMIA; VIRULENCE; VIRUS ATTACHMENT; VIRUS REPLICATION;

EID: 84959212852     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0004139     Document Type: Article

References (96)

1. Lee VJ, Chow A, Zheng X, Carrasco LR, Cook AR, et al. (2012) Simple clinical and laboratory predictors of Chikungunya versus dengue infections in adults. PLoS Negl Trop Dis6: e1786. doi: 10.1371/journal.pntd.000178623029573
2. Schilte C, Staikowsky F, Couderc T, Madec Y, Carpentier F, et al. (2013) Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study. PLoS Negl Trop Dis7: e2137. doi: 10.1371/journal.pntd.000213723556021
3. Gauri LA, Ranwa BL, Nagar K, Vyas A, Fatima Q, (2012) Post chikungunya brain stem encephalitis. J Assoc Physicians India60: 68–70. 23029750
4. Tandale BV, Sathe PS, Arankalle VA, Wadia RS, Kulkarni R, et al. (2009) Systemic involvements and fatalities during Chikungunya epidemic in India, 2006. J Clin Virol46: 145–149. doi: 10.1016/j.jcv.2009.06.02719640780
5. Pellot AS, Alessandri JL, Robin S, Samperiz S, Attali T, et al. (2012) [Severe forms of chikungunya virus infection in a pediatric intensive care unit on Reunion Island]. Med Trop (Mars)72 Spec No: 88–93.
6. Thiberville SD, Moyen N, Dupuis-Maguiraga L, Nougairede A, Gould EA, et al. (2013) Chikungunya fever: epidemiology, clinical syndrome, pathogenesis and therapy. Antiviral Res99: 345–370. doi: 10.1016/j.antiviral.2013.06.00923811281
7. Gerardin P, Guernier V, Perrau J, Fianu A, Le Roux K, et al. (2008) Estimating Chikungunya prevalence in La Reunion Island outbreak by serosurveys: two methods for two critical times of the epidemic. BMC Infect Dis8: 99. doi: 10.1186/1471-2334-8-9918662384
8. Mavalankar D, Shastri P, Bandyopadhyay T, Parmar J, Ramani KV, (2008) Increased mortality rate associated with chikungunya epidemic, Ahmedabad, India. Emerg Infect Dis14: 412–415. doi: 10.3201/eid1403.07072018325255
9. Suhrbier A, Jaffar-Bandjee MC, Gasque P, (2012) Arthritogenic alphaviruses—an overview. Nat Rev Rheumatol8: 420–429. doi: 10.1038/nrrheum.2012.6422565316
10. Benedict MQ, Levine RS, Hawley WA, Lounibos LP, (2007) Spread of the tiger: global risk of invasion by the mosquito Aedes albopictus. Vector Borne Zoonotic Dis7: 76–85. 17417960
11. Ruiz-Moreno D, Vargas IS, Olson KE, Harrington LC, (2012) Modeling dynamic introduction of Chikungunya virus in the United States. PLoS Negl Trop Dis6: e1918. doi: 10.1371/journal.pntd.000191823209859
12. Leparc-Goffart I, Nougairede A, Cassadou S, Prat C, de Lamballerie X, (2014) Chikungunya in the Americas. Lancet383: 514. doi: 10.1016/S0140-6736(14)60185-924506907
13. Abdelnabi R, Neyts J, Delang L, (2015) Towards antivirals against chikungunya virus. Antiviral Res121: 59–68. doi: 10.1016/j.antiviral.2015.06.01726119058
14. Lum FM, Ng LF, (2015) Cellular and molecular mechanisms of chikungunya pathogenesis. Antiviral Res120: 165–174. doi: 10.1016/j.antiviral.2015.06.00926092642
15. Weaver SC, Osorio JE, Livengood JA, Chen R, Stinchcomb DT, (2012) Chikungunya virus and prospects for a vaccine. Expert Rev Vaccines11: 1087–1101. doi: 10.1586/erv.12.8423151166
16. Strauss JH, Strauss EG, (1994) The alphaviruses: gene expression, replication, and evolution. Microbiol Rev58: 491–562. 7968923
17. Weaver SC, Brault AC, Kang W, Holland JJ, (1999) Genetic and fitness changes accompanying adaptation of an arbovirus to vertebrate and invertebrate cells. J Virol73: 4316–4326. 10196330
18. Tsetsarkin KA, Vanlandingham DL, McGee CE, Higgs S, (2007) A single mutation in chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog3: e201. 18069894
19. Garmashova N, Gorchakov R, Volkova E, Paessler S, Frolova E, et al. (2007) The Old World and New World alphaviruses use different virus-specific proteins for induction of transcriptional shutoff. J Virol81: 2472–2484. 17108023
20. Gorchakov R, Frolova E, Frolov I, (2005) Inhibition of transcription and translation in Sindbis virus-infected cells. J Virol79: 9397–9409. 16014903
21. Li YG, Siripanyaphinyo U, Tumkosit U, Noranate N, An A, et al. (2013) Chikungunya virus induces a more moderate cytopathic effect in mosquito cells than in mammalian cells. Intervirology56: 6–12. doi: 10.1159/00033998522907160
22. Mims CA, Day MF, Marshall ID, (1966) Cytopathic effect of Semliki Forest virus in the mosquito Aedes aegypti. Am J Trop Med Hyg15: 775–784. 5917634
23. Raghow RS, Davey MW, Dalgarno L, (1973) The growth of Semliki Forest virus in cultured mosquito cells: ultrastructural observations. Arch Gesamte Virusforsch43: 165–168. 4793529
24. Raghow RS, Grace TD, Filshie BK, Bartley W, Dalgarno L, (1973) Ross River virus replication in cultured mosquito and mammalian cells: virus growth and correlated ultrastructural changes. J Gen Virol21: 109–122. 4357368
25. Heidner HW, Knott TA, Johnston RE, (1996) Differential processing of sindbis virus glycoprotein PE2 in cultured vertebrate and arthropod cells. J Virol70: 2069–2073. 8627739
26. Leavitt R, Schlesinger S, Kornfeld S, (1977) Tunicamycin inhibits glycosylation and multiplication of Sindbis and vesicular stomatitis viruses. J Virol21: 375–385. 189071
27. Mondotte JA, Lozach PY, Amara A, Gamarnik AV, (2007) Essential role of dengue virus envelope protein N glycosylation at asparagine-67 during viral propagation. J Virol81: 7136–7148. 17459925
28. Knight RL, Schultz KL, Kent RJ, Venkatesan M, Griffin DE, (2009) Role of N-linked glycosylation for sindbis virus infection and replication in vertebrate and invertebrate systems. J Virol83: 5640–5647. doi: 10.1128/JVI.02427-0819297464
29. Vigerust DJ, Shepherd VL, (2007) Virus glycosylation: role in virulence and immune interactions. Trends Microbiol15: 211–218. 17398101
30. Moudy RM, Zhang B, Shi PY, Kramer LD, (2009) West Nile virus envelope protein glycosylation is required for efficient viral transmission by Culex vectors. Virology387: 222–228. doi: 10.1016/j.virol.2009.01.03819249803
31. Klimstra WB, Nangle EM, Smith MS, Yurochko AD, Ryman KD, (2003) DC-SIGN and L-SIGN can act as attachment receptors for alphaviruses and distinguish between mosquito cell- and mammalian cell-derived viruses. J Virol77: 12022–12032. 14581539
32. Davis CW, Nguyen HY, Hanna SL, Sanchez MD, Doms RW, et al. (2006) West Nile virus discriminates between DC-SIGN and DC-SIGNR for cellular attachment and infection. J Virol80: 1290–1301. 16415006
33. Alen MM, Dallmeier K, Balzarini J, Neyts J, Schols D, (2012) Crucial role of the N-glycans on the viral E-envelope glycoprotein in DC-SIGN-mediated dengue virus infection. Antiviral Res96: 280–287. doi: 10.1016/j.antiviral.2012.10.00723124109
34. Shabman RS, Morrison TE, Moore C, White L, Suthar MS, et al. (2007) Differential induction of type I interferon responses in myeloid dendritic cells by mosquito and mammalian-cell-derived alphaviruses. J Virol81: 237–247. 17079324
35. Silva MC, Guerrero-Plata A, Gilfoy FD, Garofalo RP, Mason PW, (2007) Differential activation of human monocyte-derived and plasmacytoid dendritic cells by West Nile virus generated in different host cells. J Virol81: 13640–13648. 17913823
36. Liu J, Thorp SC, (2002) Cell surface heparan sulfate and its roles in assisting viral infections. Med Res Rev22: 1–25. 11746174
37. Olofsson S, Bergstrom T, (2005) Glycoconjugate glycans as viral receptors. Ann Med37: 154–172. 16019714
38. Gardner CL, Hritz J, Sun C, Vanlandingham DL, Song TY, et al. (2014) Deliberate attenuation of chikungunya virus by adaptation to heparan sulfate-dependent infectivity: a model for rational arboviral vaccine design. PLoS Negl Trop Dis8: e2719. doi: 10.1371/journal.pntd.000271924587470
39. Bernard KA, Klimstra WB, Johnston RE, (2000) Mutations in the E2 glycoprotein of Venezuelan equine encephalitis virus confer heparan sulfate interaction, low morbidity, and rapid clearance from blood of mice. Virology276: 93–103. 11021998
40. Silva LA, Khomandiak S, Ashbrook AW, Weller R, Heise MT, et al. (2014) A single-amino-acid polymorphism in Chikungunya virus E2 glycoprotein influences glycosaminoglycan utilization. J Virol88: 2385–2397. doi: 10.1128/JVI.03116-1324371059
41. Gardner CL, Ebel GD, Ryman KD, Klimstra WB, (2011) Heparan sulfate binding by natural eastern equine encephalitis viruses promotes neurovirulence. Proc Natl Acad Sci U S A108: 16026–16031. doi: 10.1073/pnas.111061710821896745
42. Ryman KD, Gardner CL, Burke CW, Meier KC, Thompson JM, et al. (2007) Heparan sulfate binding can contribute to the neurovirulence of neuroadapted and nonneuroadapted Sindbis viruses. J Virol81: 3563–3573. 17215278
43. Hsieh P, Rosner MR, Robbins PW, (1983) Host-dependent variation of asparagine-linked oligosaccharides at individual glycosylation sites of Sindbis virus glycoproteins. J Biol Chem258: 2548–2554. 6822574
44. Wang R, Wang J, Paul AM, Acharya D, Bai F, et al. (2013) Mouse embryonic stem cells are deficient in type I interferon expression in response to viral infections and double-stranded RNA. J Biol Chem288: 15926–15936. doi: 10.1074/jbc.M112.42143823580653
45. Bai F, Wang T, Pal U, Bao F, Gould LH, et al. (2005) Use of RNA interference to prevent lethal murine west nile virus infection. J Infect Dis191: 1148–1154. 15747251
46. Kozaci DL, Chernajovsky Y, Chikanza IC, (2007) The differential expression of corticosteroid receptor isoforms in corticosteroid-resistant and -sensitive patients with rheumatoid arthritis. Rheumatology (Oxford)46: 579–585.
47. Paul AM, Shi Y, Acharya D, Douglas JR, Cooley A, et al. (2014) Delivery of antiviral small interfering RNA with gold nanoparticles inhibits dengue virus infection in vitro. J Gen Virol95: 1712–1722. doi: 10.1099/vir.0.066084-024828333
48. Gardner J, Anraku I, Le TT, Larcher T, Major L, et al. (2010) Chikungunya virus arthritis in adult wild-type mice. J Virol84: 8021–8032. doi: 10.1128/JVI.02603-0920519386
49. Teo TH, Lum FM, Claser C, Lulla V, Lulla A, et al. (2013) A pathogenic role for CD4+ T cells during Chikungunya virus infection in mice. J Immunol190: 259–269. doi: 10.4049/jimmunol.120217723209328
50. Teng TS, Foo SS, Simamarta D, Lum FM, Teo TH, et al. (2012) Viperin restricts chikungunya virus replication and pathology. J Clin Invest122: 4447–4460. doi: 10.1172/JCI6312023160199
51. Marsh M, Wellsteed J, Kern H, Harms E, Helenius A, (1982) Monensin inhibits Semliki Forest virus penetration into culture cells. Proc Natl Acad Sci U S A79: 5297–5301. 6957864
52. Helenius A, Marsh M, White J, (1982) Inhibition of Semliki forest virus penetration by lysosomotropic weak bases. J Gen Virol58Pt 1: 47–61.
53. Schilte C, Couderc T, Chretien F, Sourisseau M, Gangneux N, et al. (2010) Type I IFN controls chikungunya virus via its action on nonhematopoietic cells. J Exp Med207: 429–442. doi: 10.1084/jem.2009085120123960
54. Sourisseau M, Schilte C, Casartelli N, Trouillet C, Guivel-Benhassine F, et al. (2007) Characterization of reemerging chikungunya virus. PLoS Pathog3: e89. 17604450
55. Shabman RS, Rogers KM, Heise MT, (2008) Ross River virus envelope glycans contribute to type I interferon production in myeloid dendritic cells. J Virol82: 12374–12383. doi: 10.1128/JVI.00985-0818922878
56. Lim PY, Louie KL, Styer LM, Shi PY, Bernard KA, (2010) Viral pathogenesis in mice is similar for West Nile virus derived from mosquito and mammalian cells. Virology400: 93–103. doi: 10.1016/j.virol.2010.01.02920167345
57. Gardner CL, Burke CW, Higgs ST, Klimstra WB, Ryman KD, (2012) Interferon-alpha/beta deficiency greatly exacerbates arthritogenic disease in mice infected with wild-type chikungunya virus but not with the cell culture-adapted live-attenuated 181/25 vaccine candidate. Virology425: 103–112. doi: 10.1016/j.virol.2011.12.02022305131
58. Rue CA, Ryan P, (2003) A role for glycoprotein C in pseudorabies virus entry that is independent of virus attachment to heparan sulfate and which involves the actin cytoskeleton. Virology307: 12–21. 12667810
59. Leung JY, Ng MM, Chu JJ, (2011) Replication of alphaviruses: a review on the entry process of alphaviruses into cells. Adv Virol2011: 249640. doi: 10.1155/2011/24964022312336
60. Kielian M, Chanel-Vos C, Liao M, (2010) Alphavirus Entry and Membrane Fusion. Viruses2: 796–825. 21546978
61. Marsh M, Bron R, (1997) SFV infection in CHO cells: cell-type specific restrictions to productive virus entry at the cell surface. J Cell Sci110 (Pt 1): 95–103.
62. Bernard E, Solignat M, Gay B, Chazal N, Higgs S, et al. (2010) Endocytosis of chikungunya virus into mammalian cells: role of clathrin and early endosomal compartments. PLoS One5: e11479. doi: 10.1371/journal.pone.001147920628602
63. Gardner CL, Choi-Nurvitadhi J, Sun C, Bayer A, Hritz J, et al. (2013) Natural variation in the heparan sulfate binding domain of the eastern equine encephalitis virus E2 glycoprotein alters interactions with cell surfaces and virulence in mice. J Virol87: 8582–8590. doi: 10.1128/JVI.00937-1323720725
64. Klimstra WB, Ryman KD, Johnston RE, (1998) Adaptation of Sindbis virus to BHK cells selects for use of heparan sulfate as an attachment receptor. J Virol72: 7357–7366. 9696832
65. Hsieh P, Robbins P. W., (1984) Regulation of asparagine-linked oligosaccharide processing. Oligosaccharide processing in Aedes albopictus mosquito cells. J Biol Chem259: 2375–2382. 6698972
66. Voss JE, Vaney MC, Duquerroy S, Vonrhein C, Girard-Blanc C, et al. (2010) Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography. Nature468: 709–712. doi: 10.1038/nature0955521124458
67. Mishin VP, Novikov D, Hayden FG, Gubareva LV, (2005) Effect of hemagglutinin glycosylation on influenza virus susceptibility to neuraminidase inhibitors. J Virol79: 12416–12424. 16160169
68. Butters TD, Hughes RC, Vischer P, (1981) Steps in the biosynthesis of mosquito cell membrane glycoproteins and the effects of tunicamycin. Biochim Biophys Acta640: 672–686. 7213699
69. Strauss JH, Jr.Burge B. W., Darnell J. E., . (1970) Carbohydrate content of the membrane protein of Sindbis virus. J Mol Biol47: 437–448. 5418165
70. Jupille HJ, Medina-Rivera M, Hawman DW, Oko L, Morrison TE, (2013) A tyrosine-to-histidine switch at position 18 of the Ross River virus E2 glycoprotein is a determinant of virus fitness in disparate hosts. J Virol87: 5970–5984. doi: 10.1128/JVI.03326-1223514884
71. Heil ML, Albee A, Strauss JH, Kuhn RJ, (2001) An amino acid substitution in the coding region of the E2 glycoprotein adapts Ross River virus to utilize heparan sulfate as an attachment moiety. J Virol75: 6303–6309. 11413296
72. Smit JM, Waarts BL, Kimata K, Klimstra WB, Bittman R, et al. (2002) Adaptation of alphaviruses to heparan sulfate: interaction of Sindbis and Semliki forest viruses with liposomes containing lipid-conjugated heparin. J Virol76: 10128–10137. 12239287
73. La Linn M, Eble JA, Lubken C, Slade RW, Heino J, et al. (2005) An arthritogenic alphavirus uses the alpha1beta1 integrin collagen receptor. Virology336: 229–239. 15892964
74. Mitsuhashi J, Nakasone S., Horie Y, (1983) Sterol-free eukaryotic cells from continuous cell lines of insects. Cell Biol Int Rep7: 1057–1062. 6667502
75. Connell BJ, Lortat-Jacob H, (2013) Human Immunodeficiency Virus and Heparan Sulfate: From Attachment to Entry Inhibition. Front Immunol4: 385. doi: 10.3389/fimmu.2013.0038524312095
76. Trybala E, Roth A, Johansson M, Liljeqvist JA, Rekabdar E, et al. (2002) Glycosaminoglycan-binding ability is a feature of wild-type strains of herpes simplex virus type 1. Virology302: 413–419. 12441085
77. Goodfellow IG, Sioofy AB, Powell RM, Evans DJ, (2001) Echoviruses bind heparan sulfate at the cell surface. J Virol75: 4918–4921. 11312365
78. Richards KF, Bienkowska-Haba M, Dasgupta J, Chen XS, Sapp M, (2013) Multiple heparan sulfate binding site engagements are required for the infectious entry of human papillomavirus type 16. J Virol87: 11426–11437. doi: 10.1128/JVI.01721-1323966387
79. Glasgow GM, Sheahan BJ, Atkins GJ, Wahlberg JM, Salminen A, et al. (1991) Two mutations in the envelope glycoprotein E2 of Semliki Forest virus affecting the maturation and entry patterns of the virus alter pathogenicity for mice. Virology185: 741–748. 1660202
80. Wang E, Brault AC, Powers AM, Kang W, Weaver SC, (2003) Glycosaminoglycan binding properties of natural venezuelan equine encephalitis virus isolates. J Virol77: 1204–1210. 12502837
81. McKinney RW, Berge TO, Sawyer WD, Tigertt WD, Crozier D, (1963) Use of an Attenuated Strain of Venezuelan Equine Encephalomyelitis Virus for Immunization in Man. Am J Trop Med Hyg12: 597–603. 14044773
82. Roukens AH, Visser LG, (2008) Yellow fever vaccine: past, present and future. Expert Opin Biol Ther8: 1787–1795. doi: 10.1517/14712598.8.11.178718847312
83. Hoke CH, Jr.Pace-Templeton J, Pittman P, Malinoski FJ, Gibbs P, et al. (2012) US Military contributions to the global response to pandemic chikungunya. Vaccine30: 6713–6720. doi: 10.1016/j.vaccine.2012.08.02522940380
84. Lee E, Lobigs M, (2002) Mechanism of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray Valley encephalitis virus. J Virol76: 4901–4911. 11967307
85. Lee E, Lobigs M, (2008) E protein domain III determinants of yellow fever virus 17D vaccine strain enhance binding to glycosaminoglycans, impede virus spread, and attenuate virulence. J Virol82: 6024–6033. doi: 10.1128/JVI.02509-0718400851
86. Gorchakov R, Wang E, Leal G, Forrester NL, Plante K, et al. (2012) Attenuation of Chikungunya virus vaccine strain 181/clone 25 is determined by two amino acid substitutions in the E2 envelope glycoprotein. J Virol86: 6084–6096. doi: 10.1128/JVI.06449-1122457519
87. Roy CJ, Adams AP, Wang E, Plante K, Gorchakov R, et al. (2014) Chikungunya Vaccine Candidate Is Highly Attenuated and Protects Nonhuman Primates Against Telemetrically Monitored Disease Following a Single Dose. J Infect Dis.
88. Edelman R, Tacket CO, Wasserman SS, Bodison SA, Perry JG, et al. (2000) Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218. Am J Trop Med Hyg62: 681–685. 11304054
89. Lee E, Wright PJ, Davidson A, Lobigs M, (2006) Virulence attenuation of Dengue virus due to augmented glycosaminoglycan-binding affinity and restriction in extraneural dissemination. J Gen Virol87: 2791–2801. 16963737
90. Fontaine A, Diouf I, Bakkali N, Misse D, Pages F, et al. (2011) Implication of haematophagous arthropod salivary proteins in host-vector interactions. Parasit Vectors4: 187. doi: 10.1186/1756-3305-4-18721951834
91. Schneider BS, Higgs S, (2008) The enhancement of arbovirus transmission and disease by mosquito saliva is associated with modulation of the host immune response. Trans R Soc Trop Med Hyg102: 400–408. doi: 10.1016/j.trstmh.2008.01.02418342898
92. Cox J, Mota J, Sukupolvi-Petty S, Diamond MS, Rico-Hesse R, (2012) Mosquito bite delivery of dengue virus enhances immunogenicity and pathogenesis in humanized mice. J Virol86: 7637–7649. doi: 10.1128/JVI.00534-1222573866
93. Styer LM, Lim PY, Louie KL, Albright RG, Kramer LD, et al. (2011) Mosquito saliva causes enhancement of West Nile virus infection in mice. J Virol85: 1517–1527. doi: 10.1128/JVI.01112-1021147918
94. Osorio JE, Godsey MS, Defoliart GR, Yuill TM, (1996) La Crosse viremias in white-tailed deer and chipmunks exposed by injection or mosquito bite. Am J Trop Med Hyg54: 338–342. 8615443
95. Thangamani S, Higgs S, Ziegler S, Vanlandingham D, Tesh R, et al. (2010) Host immune response to mosquito-transmitted chikungunya virus differs from that elicited by needle inoculated virus. PLoS One5: e12137. doi: 10.1371/journal.pone.001213720711354
96. Conway MJ, Watson AM, Colpitts TM, Dragovic SM, Li Z, et al. (2014) Mosquito saliva serine protease enhances dissemination of dengue virus into the mammalian host. J Virol88: 164–175. doi: 10.1128/JVI.02235-1324131723